SEC Info - Laube Lynne Marie - ‘4’ for 2/20/20 re: Cardlytics, Inc.

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Laube Lynne Marie

(Last)

(First)

(Middle)

C/O CARDLYTICS, INC.

675 PONCE DE LEON AVENUE NE, SUITE 6000

(Street)

ATLANTA

30308

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Cardlytics, Inc. [ CDLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
2/20/20

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	2/20/20		S ⁽¹⁾		700	D	$96.55 ⁽²⁾	334,827	D
Common Stock	2/20/20		S ⁽¹⁾		900	D	$97.8 ⁽³⁾	333,927	D
Common Stock	2/20/20		S ⁽¹⁾		2,172	D	$98.96 ⁽⁴⁾	331,755	D
Common Stock	2/20/20		S ⁽¹⁾		1,268	D	$99.62 ⁽⁵⁾	330,487	D
Common Stock	2/20/20		S ⁽¹⁾		400	D	$100.64 ⁽⁶⁾	330,087	D
Common Stock	2/20/20		S ⁽¹⁾		300	D	$101.61 ⁽⁷⁾	329,787	D
Common Stock								18,565	I	See Footnote ⁽⁸⁾
Common Stock								18,565	I	See Footnote ⁽⁹⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

(1) These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 5, 2018, as amended May 14, 2019.

(2) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $95.93 to $96.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6) and (7) to this Form 4.

(3) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $97.25 to $98.16, inclusive.

(4) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $98.30 to $99.18, inclusive.

(5) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $99.30 to $100.25, inclusive.

(6) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $100.39 to $101.06, inclusive.

(7) The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $101.60 to $101.63, inclusive.

(8) The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Keegan George Allbright (the "KGA GRAT"). The Reporting Person is the trustee of the KGA GRAT.

(9) The reportable securities are held by the 2013 Lynne Marie Laube GRAT fbo Hayley Marie Allbright (the "HMA GRAT"). The Reporting Person is the trustee of the HMA GRAT.

Remarks:

	/s/ Kirk Somers, Attorney-in-Fact	2/20/20
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

____________ Transaction Code:
S	Open market or private sale of non-derivative or derivative security.

Laube Lynne Marie – ‘4’ for 2/20/20 re: Cardlytics, Inc.

On: Thursday, 2/20/20, at 4:55pm ET · For: 2/20/20 · Accession #: 1666071-20-31 · File #: 1-38386

Previous ‘4’: ‘4’ on / for 1/21/20 · Next: ‘4’ on 3/2/20 for 2/26/20 · Latest: ‘4’ on 5/26/23 for 5/24/23

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Laube Lynne Marie – ‘4’ for 2/20/20 re: Cardlytics, Inc.

On: Thursday, 2/20/20, at 4:55pm ET · For: 2/20/20 · Accession #: 1666071-20-31 · File #: 1-38386

Previous ‘4’: ‘4’ on / for 1/21/20 · Next: ‘4’ on 3/2/20 for 2/26/20 · Latest: ‘4’ on 5/26/23 for 5/24/23

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

This ‘4’ Document is an XML Data File that may be rendered in various formats:

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34
Filing Table of Contents